-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) Tops Q4 EPS by 9c
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $141 at Canaccord Genuity
-
-
-
-
-
-
-
Citi Starts Rhythm Pharmaceuticals (RYTM) at Buy, PT $136
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)
-
-
-
-
-
-
-
FDA accepts Rhythm Pharmaceuticals' setmelanotide filing for rare obesity
-
-
-
-
-
-
-
Citizens JMP Upgrades Rhythm Pharmaceuticals (RYTM) to Market Outperform
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $123 at Stifel
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

